+906.3%
SHOP vs MRNA
+878.5%
+27.8%
-84.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | -3.6% | +4.1% | +0.9% |
| 7D | -2.8% | -20.0% | +17.2% | -0.6% |
| 30D | -12.8% | -1.3% | -11.5% | -12.9% |
| 3M | -4.2% | +240.0% | -244.2% | -23.6% |
| 6M | +47.4% | +339.0% | -291.6% | +10.9% |
| YTD | -8.2% | +630.0% | -638.2% | -37.8% |
| 1Y | +1.2% | +769.1% | -767.9% | -33.9% |
| 3Y | +119.7% | +181.2% | -61.5% | +64.8% |
| 5Y | -11.8% | -8.1% | -3.7% | -24.0% |
| All | +906.3% | +878.5% | +27.8% | +632.9% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling